Finally, GM-CSF delivery has also been achieved clinically using allogenic breast cancer cells engineered to secrete high levels of GM-CSF, termed SV-BR-1-GM cells [134,135] (NCT00095862). The gene discussed is CSF2; the disease is breast carcinoma.